scispace - formally typeset
A

Alyson Fox

Researcher at Novartis

Publications -  53
Citations -  5677

Alyson Fox is an academic researcher from Novartis. The author has contributed to research in topics: Hyperalgesia & Nociception. The author has an hindex of 36, co-authored 53 publications receiving 5493 citations. Previous affiliations of Alyson Fox include University College London.

Papers
More filters
Journal ArticleDOI

Pain related behaviour in two models of osteoarthritis in the rat knee.

TL;DR: An analysis of pain related behaviours in two models of OA in the rat: partial medial meniscectomy and iodoacetate injection provides a basis for studies on the mechanisms of pain in OA, and for development of novel therapeutic analgesics.
Journal ArticleDOI

siRNA relieves chronic neuropathic pain

TL;DR: It is shown that RNAi can block a pathophysiological pain response and provide relief from neuropathic pain in a rat disease model by down regulating an endogenous, neuronally expressed gene.
Journal ArticleDOI

VR1 protein expression increases in undamaged DRG neurons after partial nerve injury.

TL;DR: Examination of the expression of the sensory neuron‐specific cation channel Vanilloid Receptor 1 (VR1), an important transducer of noxious stimuli, in three models of nerve injury in the rat found that VR1‐IR persisted in the transected sciatic nerve proximal to the lesion, despite its down‐regulation in the damaged neuronal somata.
Journal ArticleDOI

The VR1 Antagonist Capsazepine Reverses Mechanical Hyperalgesia in Models of Inflammatory and Neuropathic Pain

TL;DR: The data show that VR1 antagonists have antihyperalgesic activity in animal models of chronic inflammatory and neuropathic pain, and illustrate species differences in the in vivo pharmacology of VR1 that correlate with differences in pharmacology previously seen in vitro.